Results
3049
Every company on Simply Wall St ordered by total Snowflake score (not a Buy recommendation).
3049 companies
Kobo Biotech
Market Cap: ₹54.3m
Manufactures active pharmaceutical ingredients based on fermentation technology in India.
531541
₹2.28
7D
0.9%
1Y
-23.2%
NervGen Pharma
Market Cap: CA$277.0m
A biotechnology company, engages in the discovery, development, and commercialization of pharmaceutical treatments to promote nervous system repair in settings of neurotrauma and neurologic disease.
NGEN
CA$3.68
7D
1.9%
1Y
35.8%
LianBio
Market Cap: US$5.8m
A biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, opthalmology, and inflammatory diseases in China and other Asian countries.
LIAN.Y
US$0.054
7D
-6.4%
1Y
-85.0%
Neural Therapeutics
Market Cap: CA$4.2m
A drug discovery company, focuses on plant-based active substances.
NURL
CA$0.025
7D
0%
1Y
n/a
Evofem Biosciences
Market Cap: US$1.2m
A biopharmaceutical company, develops and commercializes various products to address unmet needs in women’s sexual and reproductive health.
EVFM
US$0.0098
7D
0%
1Y
12.0%
Eone Diagnomics Genome Center
Market Cap: ₩57.4b
Provides genetic information analysis services in South Korea.
A245620
₩415.00
7D
0%
1Y
-76.1%
Univo Pharmaceuticals
Market Cap: ₪2.8m
Univo Pharmaceuticals Ltd engages in the development, production, and supply of medical cannabis products.
UNVO
₪0.093
7D
0%
1Y
-94.3%
CannTrust Holdings
Market Cap: US$141.0
Produces and distributes medical and recreational cannabis in Canada.
CNTT.Q
US$0.000001
7D
0%
1Y
0%
ARYx Therapeutics
Market Cap: US$33.0
ARYx Therapeutics, Inc. discovers and develops novel therapies for large, chronic, and oral markets.
ARYX
US$0.000001
7D
0%
1Y
n/a
Xeno Transplants
Market Cap: US$4.0k
Operates as a bio-technology research and development company.
XENO
US$0.0001
7D
0%
1Y
n/a
ACC Aviation Holdings
Market Cap: US$49.9m
Focuses on developing canna powder products.
CAVG
US$0.10
7D
0%
1Y
-80.4%
Immunotech Biopharm
Market Cap: HK$2.8b
A cellular immunotherapy biopharmaceutical company, focuses on the research, development, and commercialization of T cell immunotherapy products for the treatment of cancers in the People’s Republic of China.
6978
HK$5.37
7D
1.7%
1Y
93.2%
CMG Pharmaceutical
Market Cap: ₩284.4b
A pharmaceutical company, develops and sells oral thin film (OTF) pharmaceuticals in South Korea.
A058820
₩1,926.00
7D
6.1%
1Y
-7.2%
Hebei Changshan Biochemical Pharmaceutical
Market Cap: CN¥45.0b
Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
300255
CN¥48.95
7D
-3.7%
1Y
386.1%
MJ Holdings
Market Cap: US$5.8k
A cannabis holding company, engages in cultivation management, asset, and infrastructure development business in Nevada.
MJNE
US$0.0001
7D
0%
1Y
0%
Plandaí Biotechnology
Market Cap: US$4.5m
Focuses on the production of proprietary botanical extracts for the nutriceutical and pharmaceutical industries.
PLPL
US$0.00001
7D
900.0%
1Y
-95.0%
Samjin Pharmaceuticals
Market Cap: ₩232.5b
Manufactures and sells medicine.
A005500
₩19,140.00
7D
0.5%
1Y
6.7%
Vivimed Labs
Market Cap: ₹410.4m
Vivimed Labs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, specialty chemicals, and retail branded formulations in India.
VIVIMEDLAB
₹4.95
7D
0%
1Y
-45.9%
OLIPASS
Market Cap: ₩9.6b
A biotech company, focuses on developing therapeutic products in South Korea.
A244460
₩1,651.00
7D
0%
1Y
-70.0%
West Island Brands
Market Cap: CA$2.0m
Engages in the medical marijuana business.
WIB
CA$0.13
7D
0%
1Y
4.0%
North Bud Farms
Market Cap: US$66.0
Through its subsidiaries, focuses on the production of pharmaceutical-grade cannabis and food grade cannabinoid infused inputs for the pharmaceutical and recreational cannabis markets in Canada.
NOBD.F
US$0.000001
7D
0%
1Y
n/a
Claritas Pharmaceuticals
Market Cap: US$37.0
A clinical-stage specialty pharmaceutical company, focuses on developing and commercializing therapies for patients with unmet medical needs.
CLAZ.F
US$0.000001
7D
0%
1Y
n/a
New Green Hemp
Market Cap: US$11.8m
New Green Hemp Inc. cultivates and sells hemp products.
NGHI
US$0.51
7D
102.5%
1Y
-96.0%
Affymax
Market Cap: US$59.6k
Does not have significant operations.
AFFY
US$0.0008
7D
0%
1Y
14.3%
LiveCare
Market Cap: US$1.4m
Focuses on addressing the diabetic epidemic and other chronic diseases through state-of-the-art technologies and a human-touch approach.
LVCE
US$0.023
7D
0%
1Y
n/a
Proteonomix
Market Cap: US$7.0
A biotechnology company, focuses on developing therapeutics based upon the use of human cells and their derivatives.
PROT
US$0.000001
7D
0%
1Y
n/a
Cambium Bio
Market Cap: AU$11.8m
A clinical-stage regenerative medicine company, focuses on developing biologics for ophthalmology and tissue repair applications.
CMB
AU$0.52
7D
9.6%
1Y
71.7%
Jiangsu CoWin Biotech
Market Cap: CN¥2.9b
Engages in the research and development, production, and sale of biological products in China.
688426
CN¥26.24
7D
13.6%
1Y
56.0%
Cellid
Market Cap: ₩121.0b
Develops immunotherapeutic vaccines for cancer and/or infectious diseases therapies.
A299660
₩4,100.00
7D
6.1%
1Y
-36.8%
Fujian Cosunter Pharmaceutical
Market Cap: CN¥18.1b
Engages in the research and development, manufacture, and sale of pharmaceutical products in China.
300436
CN¥113.38
7D
-13.8%
1Y
516.2%
Medican Enterprises
Market Cap: US$46.5k
A bio-pharmaceutical company, focuses on pursuing business opportunities in the medical and recreational marijuana sector.
MDCN
US$0.000001
7D
0%
1Y
0%
Epigenomics
Market Cap: €762.9k
Does not have significant operations.
ECX
€0.87
7D
0%
1Y
35.5%
Scancell Holdings
Market Cap: UK£90.3m
A clinical stage biopharmaceutical company, engages in the discovery and development of novel immunotherapies and vaccines for the treatment of cancer and infectious disease.
SCLP
UK£0.087
7D
-13.0%
1Y
-50.3%
CBD of Denver
Market Cap: US$2.0m
Engages in developing and commercializing cannabidiol (CBD) products.
CBDD
US$0.00015
7D
-25.0%
1Y
-66.7%
9 Meters Biopharma
Market Cap: US$2.8m
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders in North America.
NMTR
US$0.20
7D
-71.1%
1Y
-96.0%
Tibet Pharmaceuticals
Market Cap: US$14.0
A specialty pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Tibetan medicines.
TBET
US$0.000001
7D
0%
1Y
n/a